XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Subscription Receivable
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 1,273 $ 5 $ 17,342,559 $ (16,761,512) $ 582,325
Balance (in Shares) at Dec. 31, 2020 12,727,820 52,782        
Sale of common stock, net of offering costs $ 40 1,592,932 1,592,972
Sale of common stock, net of offering costs (in Shares) 403,024 1,675        
Common stock issued for common stock issuable $ 5 $ (5)
Common stock issued for common stock issuable (in Shares)   51,018 (51,143)        
Common stock issued for services $ 21 469,979 470,000
Common stock issued for services (in Shares) 205,000        
Net loss for the period (996,771) (996,771)
Balance at Mar. 31, 2021 $ 1,339 19,405,470 (17,758,283) 1,648,526
Balance (in Shares) at Mar. 31, 2021 13,386,862 3,314        
Balance at Dec. 31, 2020 $ 1,273 $ 5 17,342,559 (16,761,512) 582,325
Balance (in Shares) at Dec. 31, 2020 12,727,820 52,782        
Net loss for the period             (3,492,929)
Balance at Sep. 30, 2021 $ 1,957 46,256,474 (234,543) (20,254,441) 25,769,447
Balance (in Shares) at Sep. 30, 2021 19,568,833 1,389        
Balance at Mar. 31, 2021 $ 1,339 19,405,470 (17,758,283) 1,648,526
Balance (in Shares) at Mar. 31, 2021 13,386,862 3,314        
Common stock to be issued cancelled (1,000) (1,000)
Common stock to be issued cancelled (in Shares) (250)        
Accretion of stock-based compensation 100,000 100,000
Fractional shares due to reverse split
Fractional shares due to reverse split (in Shares) 21        
Sale of common stock, net of offering costs (3,735) (3,735)
Sale of common stock, net of offering costs (in Shares) 525        
Common stock issued for common stock issuable
Common stock issued for common stock issuable (in Shares) 1,675 (1,675)        
Net loss for the period (645,779) (645,779)
Balance at Jun. 30, 2021 $ 1,339 19,500,735 (18,404,062) 1,098,012
Balance (in Shares) at Jun. 30, 2021 13,389,083 1,389        
Common stock issued for exercise of Series A warrants $ 285 14,213,628 (234,543) 13,979,370
Common stock issued for exercise of Series A warrants (in Shares) 2,854,199        
Stock-based compensation in connection with stock option grants 359,607 359,607
Accretion of stock-based compensation 100,000   100,000
Sale of common stock, net of offering costs $ 333 12,082,504 12,082,837
Sale of common stock, net of offering costs (in Shares) 3,325,551        
Net loss for the period (1,850,379) (1,850,379)
Balance at Sep. 30, 2021 $ 1,957 46,256,474 (234,543) (20,254,441) 25,769,447
Balance (in Shares) at Sep. 30, 2021 19,568,833 1,389        
Balance at Dec. 31, 2021 $ 1,960 47,672,600 (27,590,546) 20,084,014
Balance (in Shares) at Dec. 31, 2021 19,597,419 1,389        
Accretion of stock based compensation in connection with stock option grants 822,583 822,583
Accretion of stock-based professional fees in connection with stock option grants and shares 202,275 202,275
Net loss for the period (3,365,846) (3,365,846)
Balance at Mar. 31, 2022 $ 1,960 48,697,458 (30,956,392) 17,743,026
Balance (in Shares) at Mar. 31, 2022 19,597,419 1,389        
Balance at Dec. 31, 2021 $ 1,960 47,672,600 (27,590,546) 20,084,014
Balance (in Shares) at Dec. 31, 2021 19,597,419 1,389        
Net loss for the period             (8,604,263)
Balance at Sep. 30, 2022 $ 2,060 51,433,628 (36,194,809) 15,240,879
Balance (in Shares) at Sep. 30, 2022   20,597,419 1,389        
Balance at Mar. 31, 2022 $ 1,960 48,697,458 (30,956,392) 17,743,026
Balance (in Shares) at Mar. 31, 2022 19,597,419 1,389        
Accretion of stock based compensation in connection with stock option grants 772,196 772,196
Accretion of stock-based professional fees in connection with stock option grants and shares 35,285 35,285
Shares issued for asset acquisition $ 100 1,089,900 1,090,000
Shares issued for asset acquisition (in Shares) 1,000,000        
Net loss for the period (2,581,712) (2,581,712)
Balance at Jun. 30, 2022 $ 2,060 50,594,839 (33,538,104) 17,058,795
Balance (in Shares) at Jun. 30, 2022 20,597,419 1,389        
Accretion of stock based compensation in connection with stock option grants 787,585 787,585
Accretion of stock-based professional fees in connection with stock option grants and shares 51,204 51,204
Net loss for the period (2,656,705) (2,656,705)
Balance at Sep. 30, 2022 $ 2,060 $ 51,433,628 $ (36,194,809) $ 15,240,879
Balance (in Shares) at Sep. 30, 2022   20,597,419 1,389